Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, P.R. China.
Department of Intensive care unit, Changsha Central Hospital of Nanhua University, Changsha, Hunan, P.R. China.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963035. doi: 10.1177/1753466620963035.
To investigate clinical characteristics and identify risk factors for severity of coronavirus disease 2019 (COVID-19) pneumonia outside of Wuhan, China.
We included 213 patients with confirmed COVID-19 who had been discharged or died by 15 March 2020. We retrospectively collected epidemiological, clinical, laboratory, computed tomography imaging and outcome data. Clinical characteristics were described and relative risk factors were compared.
Most clinical characteristics of this study were similar to those from studies in Wuhan, but there were lower mortality rate and milder severity. The median time from onset of symptoms to confirmation and hospitalization was 4 and 5 days, respectively. The median virus clearance and shedding times were 10 and 15 days, respectively. When the severe/critical group was compared with the mild/moderate group, significant risk factors included: older age; dyspnea; hypertension; poor appetite; fatigue; higher white cell count, neutrophil count, prothrombin time, creatine kinase, creatine kinase-MB, D-dimer, alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and C-reactive protein; and lower lymphocyte count and albumin ( < 0.05). In the intensive care unit (ICU) group compared with the non-ICU group, risk factors included: older age; chronic obstructive pulmonary disease (COPD); dyspnea; poor appetite; higher white cell count, D-dimer, ALT, AST and LDH; and lower lymphocyte count and albumin ( < 0.05). Independent risk factors associated with the severe/critical group were dyspnea [odds ratio (OR) = 19.48], ALT (OR = 6.02) and albumin (OR = 3.36). Independent risk factors associated with the ICU group were dyspnea (OR = 8.88), COPD (OR = 31.80), D-dimer (OR = 8.37), ALT (OR = 28.76) and LDH (OR = 9.95) ( < 0.05).
The severity of COVID-19 outside Wuhan, China was milder than that within Wuhan. The clinical infective period was long, and the longest virus shedding time was 35 days. The most important risk factors were dyspnea, COPD, D-dimer, ALT, LDH and albumin.
研究中国武汉以外地区 2019 年冠状病毒病(COVID-19)肺炎的临床特征,并确定其严重程度的危险因素。
我们纳入了 213 例已出院或于 2020 年 3 月 15 日前死亡的确诊 COVID-19 患者。我们回顾性收集了流行病学、临床、实验室、计算机断层扫描成像和结局数据。描述了临床特征,并比较了相对危险因素。
本研究的大多数临床特征与武汉的研究相似,但死亡率较低,严重程度较轻。从症状出现到确诊和住院的中位时间分别为 4 天和 5 天。病毒清除和排出的中位时间分别为 10 天和 15 天。与轻症/中度组相比,重症/危重组的显著危险因素包括:年龄较大;呼吸困难;高血压;食欲不佳;乏力;白细胞计数、中性粒细胞计数、凝血酶原时间、肌酸激酶、肌酸激酶同工酶、D-二聚体、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)和 C 反应蛋白较高;淋巴细胞计数和白蛋白较低( < 0.05)。与非 ICU 组相比,在 ICU 组中,危险因素包括:年龄较大;慢性阻塞性肺疾病(COPD);呼吸困难;食欲不佳;白细胞计数、D-二聚体、ALT、AST 和 LDH 较高;淋巴细胞计数和白蛋白较低( < 0.05)。与重症/危重组相关的独立危险因素是呼吸困难(比值比[OR] = 19.48)、ALT(OR = 6.02)和白蛋白(OR = 3.36)。与 ICU 组相关的独立危险因素是呼吸困难(OR = 8.88)、COPD(OR = 31.80)、D-二聚体(OR = 8.37)、ALT(OR = 28.76)和 LDH(OR = 9.95)( < 0.05)。
中国武汉以外地区 COVID-19 的严重程度比武汉地区轻。临床感染期较长,最长病毒排出时间为 35 天。最重要的危险因素是呼吸困难、COPD、D-二聚体、ALT、LDH 和白蛋白。